News

Pfizer, BioNTech and rna

BioNTech reiterated its guidance for 2025 revenues of 1.7 billion to 2.2 billion euros, down from 2.75 billion last year.
Should you get vaccinated? Will your insurer pay for it? And will you still be able to find a vaccine? KFF Health News tries to sort out where things stand.
Summer heat, outdoor fun … and cold and flu symptoms? The three may not go together in many people’s minds: partly owing to ...
The European Union acknowledged for the first time that a top official reviewed the messages, but said it had no duty to keep ...
Pfizer’s clinical trials in children 5 to 11 did not measure the vaccine’s effectiveness against COVID-19. Effectiveness was “never the intended primary endpoint,” Anderson said.
Sally Susman says there's no average day in her field and explains why she doesn't see comms as a 'soft skill.' ...
London — U.S. drugmaker Pfizer said Monday that human trials suggest its coronavirus vaccine is 90% effective at preventing COVID-19 infections in people not known to have had the virus already.
Pfizer, one of the front-runners in the quest for a COVID-19 vaccine, said its candidate vaccine looks safe, and the company expects to have data next month on how well it protects people against ...
HHS Secretary Robert F. Kennedy Jr. has upended the way Covid vaccines are approved and for whom they’re recommended, ...